FAMI
EW icon

Fideuram Asset Management (Ireland)’s Edwards Lifesciences EW Stock Holding History

Fideuram Asset Management (Ireland)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.61M Buy
76,762
+75,990
+9,843% +$6.37M 0.13% 226
2026
Q1 		$59.3K Sell
772
-5,941
-88% -$490K 0.01% 419
2025
Q4 		$485K Buy
+6,713
New +$551K 0.04% 318

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Fideuram Asset Management (Ireland)'s EW Position: Q2 2026 in Review

Fideuram Asset Management (Ireland) increased its Edwards Lifesciences (EW) stake by 9,843% in Q2 2026, buying an estimated $6.37M and bringing the position to 76,762 shares worth $6.61M. The position accounts for 0.13% of the portfolio, ranked #226.

Fideuram Asset Management (Ireland) first reported a position in EW in Q4 2025 and has held it in 3 quarters since. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Fideuram Asset Management (Ireland) held 76,762 shares of Edwards Lifesciences worth $6.61M as of Q2 2026.
  • Fideuram Asset Management (Ireland) bought 75,990 Edwards Lifesciences shares in Q2 2026, an estimated $6.37M.
  • Edwards Lifesciences made up 0.13% of Fideuram Asset Management (Ireland)'s portfolio in Q2 2026, its #226 holding.
  • Fideuram Asset Management (Ireland) first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 3 quarters since.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Fideuram Asset Management (Ireland)'s 13F filing for Q2 2026, filed 23 Jul 2026.